The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
MicroRNA-21 ISH analysis to predict DFS in pancreatic cancer patients undergoing adjuvant gemcitabine after curative surgery.
Soichiro Morinaga
No relevant relationships to disclose
Yoshiyasu Nakamura
No relevant relationships to disclose
Yusuke Katayama
No relevant relationships to disclose
Sho Sawazaki
No relevant relationships to disclose
Koji Numata
No relevant relationships to disclose
Kosei Higuchi
No relevant relationships to disclose
Teni Godai
No relevant relationships to disclose
Manabu Shiozawa
No relevant relationships to disclose
Yohei Miyagi
No relevant relationships to disclose
Shinichi Ohkawa
No relevant relationships to disclose
Kameda Yoichi
No relevant relationships to disclose
Makoto Akaike
No relevant relationships to disclose